Panbela to host fourth quarter and year end 2023 earnings conference call on march 26, 2024

Minneapolis, march 12, 2024 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), (“panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will host a conference call on march 26, 2024, at 4:30 pm eastern time to discuss results for its fourth quarter and year ended december 31, 2023.
PBLA Ratings Summary
PBLA Quant Ranking